Shot chasers: big pharma’s covid-19 boost
The Intelligence from The Economist
00:00
Pharma's New Image: Innovation Amidst a Pandemic
This chapter examines the transformation in the pharmaceutical industry's reputation during the COVID-19 pandemic, as companies prioritize vaccine development and equitable access. It contrasts past criticisms with a newfound focus on collaboration and innovation, particularly regarding vaccine distribution to developing nations. The conversation also addresses ethical dilemmas and the necessity for a balanced approach to patents and access in global health emergencies.
Transcript
Play full episode
